tapebrief
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

FTV · Q1 2025 Earnings

Fortive

Reported June 10, 2025

30-second summary

Fortive printed a soft quarter on a total-company basis — core revenue declined 2%, total revenue down 3%, with adjusted operating profit of $373M and adjusted EPS of $0.85 (+2% YoY) — while management used the call to quantify $190–220M of gross tariff exposure and push the Precision Technology recovery out to 2026. The new FY25 adjusted EPS range of $3.80–$4.00 (total Fortive, pre-separation) is explicitly "all in, including the impact of tariffs," and PT core revenue is now guided down low-single-digit. Importantly, the PT recovery deferral primarily affects Ralliant post-spin (separation effective end of Q2, distribution June 28, 2025); New Fortive's core growth outlook was reaffirmed. This is a holding-pattern quarter ahead of the June 10 Investor Day and end-Q2 separation; the operating story is tariff offset execution and whether the customer "pause" in Test & Measurement stays a pause.

Headline numbers

EPS

Q1 FY2025

$0.55

Revenue

Q1 FY2025

$0.99B

+0.9% YoY

Gross margin

Q1 FY2025

64.2%

Free cash flow

Q1 FY2025

$0.17B

Operating margin

Q1 FY2025

16.6%

Key financials

Q1 FY2025
MetricQ1 FY2025YoY
Revenue$0.99B+0.9%
EPS$0.55
Gross margin64.2%
Operating margin16.6%
Free cash flow$0.17B

Guidance

Prior quarter data unavailable — comparison not possible.

Segment KPIs

Q1 FY2025
SegmentQ1 FY2025YoY
Intelligent Operating Solutions$0.691B+0.9%
Advanced Healthcare Solutions$0.302B+0.8%

Other KPIs

Q1 FY2025
SegmentQ1 FY2025
Adjusted Gross Profit Margin64.4%
Adjusted Operating Profit Margin26.2%
Adjusted EBITDA Margin27.9%
Core Revenue Growth2.2%
IOS Adjusted Operating Profit Margin32.5%
AHS Adjusted Operating Profit Margin21.9%
Free Cash Flow from Continuing Operations0.171 bn

Management tone

The tone is markedly more cautious and operationally detailed than Fortive's typical earnings posture. CEO Jim Lico's commentary reframes tariffs as a managed headwind with a structured offset plan, while incoming CFO Mark's inaugural remarks emphasize "financial discipline" and capital allocation — signaling tighter cost controls into the spinoff.

The Precision Technology recovery has slipped a full year — but it's a Ralliant problem post-spin. Management entered 2025 expecting a second-half order recovery in semiconductor and electronics R&D capex; this quarter that thesis was withdrawn. From the call: "customers have just taken a pause...we started to see things getting better in the second half from an order perspective. But what we saw in the quarter was really people taking that pause...they're not certain as to when their buying cycle will start again." PT core is now guided down low-single-digit for the year with recovery pushed to 2026. With the Ralliant distribution effective June 28, 2025, the 2026 recovery primarily affects Ralliant shareholders, not New Fortive holders post-separation — New Fortive's core growth outlook was reaffirmed.

Tariffs moved from "manageable" to a quantified $190–220M problem with a structured offset plan. Management's framing here is deliberate: "policy and trade landscape has evolved significantly in the past 30 days...we expect to fully offset the estimated tariff exposure by the fourth quarter of 2025 and be neutral in 2026." The shift from opportunistic mitigation language to a phased, dated commitment is meant to anchor investor expectations — but it requires pricing execution and manufacturing rebalancing to land on schedule. Exposure splits roughly 60/40 between New Fortive and Ralliant.

The portfolio narrative is now defensive rather than offensive. Prior commentary emphasized secular growth exposure; this quarter management pivoted to: "Despite the delayed recovery we see in precision technology, we have a diverse set of new markets with exposure to strong secular trends." That's the language of a company asking investors to look past one weak segment to the rest of the book — a notable shift in posture from a company that historically leads with growth.

Even the maintained guide carries a contingency. New Fortive's core growth outlook was reaffirmed, but with explicit hedging: "includes a contingency for more muted demand that can impact pockets of IOS and AHS in 2025 as government customers navigate budget uncertainty." Reaffirming a number while widening its risk envelope is a cautious tell — the headline didn't change but the confidence band did.

Recurring themes management leaned on this quarter:

Tariff mitigation strategy: pricing power, manufacturing rebalancing, localized production accelerationTest & Measurement demand delay: customer pause on R&D CapEx pending tariff strategy clarity, not cancellationsRecurring revenue and software resilience as portfolio ballastGeographic divergence: North America strength vs. Western Europe and China weaknessSeparation execution on track with June 10 Investor Day and end-Q2 spinoff target

Risks management surfaced:

Tariff escalation: assumes July 9 reprieve expires and all tariffs continue through year; Mexico tariffs if they materializePT demand recovery extended: semiconductor and electronics CapEx cycle pushed into 2026Government spending uncertainty: state/local budget constraints impacting IOS/AHS pockets, particularly Q2 for GordianWestern Europe weakness: EV mobility and automotive investment pullback, pressure on EA Electro organic growthDefense approval delays: government validation/verification timing variation impacting sensor/safety systems shipments

What to watch into next quarter

Tariff offset execution pace — management committed to full offset by Q4 FY2025. Watch Q2 gross margin trajectory and any color on pricing actions and manufacturing relocation milestones; any slippage on the offset timeline reopens the structural margin question.

Precision Technology order book — management expects "modest improvement from Q1 in Q2." If PT orders fail to inflect sequentially, the 2026 recovery thesis is at risk and the FY guide low-end becomes the base case.

Spinoff completion and standalone disclosures — separation targeted for end of Q2 FY2025 with June 10 Investor Day; Ralliant distribution effective June 28, 2025. Watch the standalone capital structure, New Fortive's cost base post-separation, and independent guidance to be issued on Q2 earnings calls in July.

Gordian Q2 FY2025 trajectory — strong Q1 FY2025 procurement (double-digits); watch state/local budget signals as Q2 is seasonally Gordian's biggest quarter.

Western Europe and China stabilization — EA Electro organic growth and China revenue ($85.0M this quarter) need to stop deteriorating for the FY guide to hold.

Sources

  1. Fortive Q1 FY2025 supplemental press release: https://www.sec.gov/Archives/edgar/data/1659166/000165916625000093/newfortivesupplementals.htm
  2. Fortive Q1 FY2025 earnings call transcript (management prepared remarks, as supplied in extraction inputs).

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.